-
Double Top in Cyclicals?
Posted by Eddy Elfenbein on February 23rd, 2011 at 11:15 amThe stock market is getting knocked again today, but the pain isn’t evenly spread out. Who’s up for another look at the relative strength of cyclicals? Great–me, too!
As long-term readers know, one of my favorite metrics to follow is the Morgan Stanley Cylical Index (^CYC) divided by the S&P 500 (^SPX). This is far from a comprehensive analysis but it is a quick-and-dirty look at the “mind of the market.”
Since late August, the market’s rally has been disproportionally powered by cyclical stocks. In fact, the ratio of the CYC to the S&P 500 reached an all-time high on February 11th (my data goes back to 1978).
The ratio hit a previous peak on January 10th, and soon after, cyclicals dropped off sharply. I quickly jumped on this and thought it was the end of the cycle. Wrong! The ratio soon rallied and peaked on February 11th, just a hair above the level for January 10th (0.8442 to 0.8441).
The CYC is down again today (although many energy names are up). If today’s numbers hold up, the ratio will close below the low made on January 21st.
The reason these cycles are so important is that once they get going, they often last for a few years. Put it this way: if the Dow had kept pace with the CYC since the low from two years ago, today the Dow would be over 24,000 today.
-
$60 For Every Man, Woman and Child
Posted by Eddy Elfenbein on February 23rd, 2011 at 7:50 amWalmart (WMT) released its earnings report yesterday. I’m always astounded by the size of this company. For 2010, Walmart had sales of $418.52 billion. That works out to an average of $1.14 billion in sales every day of the year—or nearly $50 million every hour of the day. Another way to think about it is that it’s equal to roughly $60 in sales for every man, woman and child on planet earth.
Despite what many critics may think, Walmart’s profit margins are very small. For 2010, Walmart’s gross margins worked out to 25.3%.
Gross margin refers to the profit compared to the variable cost of each item. If we go down another level to operating profit, which includes fixed costs, Walmart’s profit is just over 6%. Then when we get to post-tax net income, Walmart’s profit margin is just 4%.
As impressive as Walmart’s numbers are, ExxonMobil (XOM) will probably top them this year. The current consensus is that XOM will have revenue of $460 billion this year.
-
Morning News: February 23, 2011
Posted by Eddy Elfenbein on February 23rd, 2011 at 7:47 amPound Rises After BOE Minutes Reveal 6-To-3 Split Vote
Oil Rises on Libya Turmoil; Euro, Pound Rally, Stocks Decline
South Korea Sanctions Deutsche Unit for Market Manipulation
ECB Rejects EU Call to Become Ratings Provider
HK Government To Sell HK$5 Billion-HK$10 Billion Inflation-Linked Bonds
Nasdaq Mulls NYSE Bid in Exchange Deal Dash
Bank Closings Tilt Toward Poor Areas
HP Shares Plunge as Sales, Outlook Lag Street
Toll Brothers Reports First-Quarter Profit as Luxury-Home Demand Revives
Holly to Pay $2.9 Billion for Frontier Oil in All-Stock Deal
Best Buy Shuts China Stores to Focus on More Profitable Brand
Danish Maersk Returned to Profit in 2010 as Container Market Grew
James Altucher on Pundit Review Radio
Paul Kedrosky: How Institutional Investors Destabilize Commodity Markets
-
Ouch! Dow Drops 178 Points
Posted by Eddy Elfenbein on February 22nd, 2011 at 5:03 pmServes me right for boasting. Right after I tell you how well the Buy List has been doing for the year, we get smacked down today.
This was an ugly day of trading. All told, the S&P 500 dropped 2.05% making it the market’s worst day since August 11, 2010. Plus, oil gained more than 6% on tensions in the Middle East. Some are now talking about oil hitting $200 per barrel.
The S&P 500 is still holding above its 50-DMA. This was the 119th day in a row that the index has been above its 50-DMA. That’s the 10th-longest run since 1932. Tomorrow we’ll have a chance to tie the ninth-best streak which happened 40 years ago.
The Buy List dropped 2.25% today. Leucadia National (LUK) was especially hard-hit as it lost 5.93%. LUK owns a stake in Fortescue Metals Group and that company lost a court ruling last week. JPMorgan Chase (JPM) and Wright Express (WXS) were also hit hard.
-
The S&P 500 Is Still Below 16 Times Earnings
Posted by Eddy Elfenbein on February 22nd, 2011 at 2:18 pmHere’s a look at the S&P 500 and its earnings. The index is the black line and it follows the left scale. The trailing four-quarter operating earnings is the gold line and it follows the right scale. The two lines are scaled at a ratio of 16-to-1 so whenever the lines cross, the P/E Ratio is exactly 16.
The black line has almost caught up to the gold line. The market hasn’t had its P/E Ratio at 16 since last May. The Double Dip hysteria of last summer brought the S&P 500 down below 1,030 and the P/E Ratio got as low as 13.62 which was a 20-year low.
There’s nothing magical about 16. It seems to be the number that the market most likes to track. The future part of the earnings line is Wall Street’s projection.
For 2011, Wall Street sees the S&P 500 earning 96.14. At a 16 P/E Ratio that means the market would be at 1,538.24 by year’s end. That’s a 14.5% rise from Friday’s close.
-
Gilead Sciences to Acquire Calistoga for $375M
Posted by Eddy Elfenbein on February 22nd, 2011 at 11:47 amGilead Sciences (GILD) makes a move:
Gilead Sciences Inc., a drug research company, said Tuesday it has agreed to acquire privately held biotechnology company Calistoga Pharmaceuticals Inc. for $375 million, expanding its research capabilities into cancer-fighting drugs.
Seattle-based Calistoga could earn up to an additional $225 million if certain milestones are achieved.
Gilead, which has specialized in HIV drugs and developed the flu fighting drug Tamiflu, anticipates closing the deal in the second quarter, subject to satisfaction of certain conditions. The company plans to finance the acquisition through available cash on hand.
Calistoga focuses on the development of medicines to treat cancer and inflammatory diseases. It is researching a drug, CAL-101, that may help fight non-Hodgkin’s lymphoma and help treat in elderly patients a specific type of leukemia.
“Oncology remains an area of significant unmet medical need and our increased understanding of the genetic basis of cancer allows for the development of disease specific targeted therapies,” said Gilead’s Chief Scientific Officer Norbert W. Bischofberger. “We are very encouraged by emerging clinical data for CAL-101, and this compound could represent an advance for the treatment of certain hematological cancers.”
-
Consumer Confidence Hits Three-Year High
Posted by Eddy Elfenbein on February 22nd, 2011 at 11:10 amMore good economic news:
Confidence among U.S. consumers rose in February to the highest level in three years as Americans became more optimistic about their incomes and the economy.
The Conference Board’s index of sentiment increased to 70.4, the highest since February 2008, from 64.8 the prior month, figures from the New York-based private research group showed today. Economists projected the gauge would be little changed at 65.5, according to the median forecast in a Bloomberg News survey.
A pickup in optimism and job gains may encourage Americans to increase purchases, bolstering consumer spending, the biggest part of the economy. At the same time, unemployment at 9 percent or higher for almost two years and mounting home foreclosures threaten to restrain households.
“The consumer believes that growth is picking up pace,” said Jonathan Basile, senior economist at Credit Suisse in New York, whose forecast of 70 for the index was the most accurate. “The ducks are in a row for stronger consumer spending this year.”
-
Medtronic Earns 86 Cents Per Share
Posted by Eddy Elfenbein on February 22nd, 2011 at 8:51 amThis morning, Medtronic (MDT) reported earnings of 86 cents per share for its fiscal third quarter. That matched exactly what I said I was expecting in the most recent issue of CWS Market Review. The consensus on Wall Street was for 83 cents per share. I’m not sure if that will be enough to off-set a sluggish market mood today.
Medtronic’s revenue rose 3% to nearly $4 billion. The company also said it would cut 1,500 to 2,000 jobs as part of its restructuring efforts. I’m not happy to see those folks lose their jobs but it’s a move MDT needs to make.
I decided to stick with Medtronic on this year’s Buy List even though the company had lowered its guidance twice during 2010. Normally, that would have me running from a stock but I still think Medtronic is a decent value.
I also expected MDT to narrow its full-year guidance which they did. Earlier, Medtronic had said it was expecting earnings-per-share to range between $3.38 to $3.44. Now the range is $3.38 to $3.40 per share. That implies fiscal Q4 earnings between 91 and 93 cents per share.
Here’s a look at Medtronic’s quarterly sales and EPS for the last several years:
Quarter EPS Sales in Millions Jul-01 $0.28 $1,456 Oct-01 $0.29 $1,571 Jan-02 $0.30 $1,592 Apr-02 $0.34 $1,792 Jul-02 $0.32 $1,714 Oct-02 $0.34 $1,891 Jan-03 $0.35 $1,913 Apr-03 $0.40 $2,148 Jul-03 $0.37 $2,064 Oct-03 $0.39 $2,164 Jan-04 $0.40 $2,194 Apr-04 $0.48 $2,665 Jul-04 $0.43 $2,346 Oct-04 $0.44 $2,400 Jan-05 $0.46 $2,531 Apr-05 $0.53 $2,778 Jul-05 $0.50 $2,690 Oct-05 $0.54 $2,765 Jan-06 $0.55 $2,770 Apr-06 $0.62 $3,067 Jul-06 $0.55 $2,897 Oct-06 $0.59 $3,075 Jan-07 $0.61 $3,048 Apr-07 $0.66 $3,280 Jul-07 $0.62 $3,127 Oct-07 $0.58 $3,124 Jan-08 $0.63 $3,405 Apr-08 $0.78 $3,860 Jul-08 $0.72 $3,706 Oct-08 $0.67 $3,570 Jan-09 $0.71 $3,494 Apr-09 $0.78 $3,830 Jul-09 $0.79 $3,933 Oct-09 $0.77 $3,838 Jan-10 $0.77 $3,851 Apr-10 $0.90 $4,196 Jul-10 $0.80 $3,773 Oct-10 $0.82 $3,903 Jan-11 $0.86 $3,961 Apr-11 $0.91 to $0.93 est $4,300 est. Here’s an eye-opening look at Medtronic’s stock along with its earnings-per-share:
-
Morning News: February 22, 2011
Posted by Eddy Elfenbein on February 22nd, 2011 at 7:37 amEuropean Stocks Tumble; Libya Woes Intensify
Oil Spikes and Stocks Fall as Unrest Intensifies
India Expects More Global Bids For Oil, Gas Fields Post BP Entry
Emergency Borrowing From ECB Still at High Level
BRICs Losing for Second Time in Decade as America Takes Over
U.S. Consumer Bureau Says Credit-Card Rules Curtail Rates, Fees
Farmers Can’t Meet Demand as Corn Stocks Drop to 1974 Low
Home Depot Quarterly Profit Rises 72% on Customer Visits
Refiners Holly, Frontier Oil to Merge in $7 Billion Deal
Mining Giant BHP Billiton to Buy Chesapeake Shale Assets For $4.75 Billion
Blockbuster Gets ‘Stalking Horse’ Bid For Company From Group
Dynegy’s Top Executives to Resign in Wake of Failed Deals
Top 100 Entrepreneurs Who Made Millions Without A College Degree
Joshua Brown: You Can Disregard this Meaningless NYT “Blogging is Dead” Story
-
Buy List YTD
Posted by Eddy Elfenbein on February 21st, 2011 at 8:36 amThe Buy List is doing pretty well so far. Through Friday, the Buy List is up 8.20% for the year compared with 6.79% for the S&P 500.
Including dividends, the Buy List is up 8.42% compared with 7.07% for the S&P 500.
-
-
Archives
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005